Navigation Links
QED Program Call for Submissions; Science Center Seeks Academic Technologies with Commercial Potential
Date:5/19/2017

The University City Science Center is seeking proposals for its QED Proof-of-Concept Program. Academic researchers with technologies ripe for commercialization, and who are affiliated with the 21 partner academic and research institutions in Pennsylvania, New Jersey and Delaware, are encouraged to submit proposals. QED, now in its tenth round, is the first multi-institutional proof-of-concept program for the life sciences and healthcare IT. The program provides academic researchers with mentoring, business advice, and in some cases, funding to commercialize their early-stage technologies.

The QED Selection Team comprised of industry experts and investors will select 10-15 applications as program participants. Program participants will be paired with Business Advisors and work to develop proof-of-concept plans to commercialize their technologies. Up to four projects will receive up to $200,000 each for technical proof-of-concept validation over a 12-month period.

Funding for each project is contributed equally by the Science Center and by the researcher’s home institution. Ownership of all intellectual property is retained by the research institution and transitioned into licensing opportunities or new ventures according to institutional policies and commercial interest.

Early submission for proposals is June 2. Researchers submitting proposals by this deadline will receive feedback from the Science Center and have the opportunity to revise and resubmit their proposals. The final submission deadline is June 29.

Since the program’s inception in 2009, QED has screened 539 proposals from 21 partner academic and research institutions. Of the technologies screened, 105 projects have been accepted into the competitive program and paired with Business Advisors. QED has awarded a total of $5.45 million to 31 projects, primarily in the therapeutic/biologic, device/diagnostic, and healthcare IT sectors. Of these 31 projects, nine technologies have been licensed, while six have gone on to form startup companies. Projects awarded funding by the QED Program have raised over $19 million in follow-on funding.

QED has received support from the U.S. Economic Development Administration, Pennsylvania Department of Community and Economic Development, the Commonwealth of Pennsylvania’s Department of Health, the Philadelphia Industrial Development Corporation, William Penn Foundation, and Wexford Science and Technology.

About the Science Center
Located in the heart of uCity Square, the Science Center is a mission-driven nonprofit organization that catalyzes and connects innovation to entrepreneurship and technology commercialization. For 50+ years, the Science Center has supported startups, research, and economic development in the life sciences, healthcare, physical sciences, and emerging technology sectors. As a result, graduate firms and current residents of the Science Center’s incubator support one out of every 100 jobs in the Greater Philadelphia region and drive $13 billion in economic activity in the region annually. By providing resources and programming for any stage of a business’s lifecycle, the Science Center helps scientists, entrepreneurs and innovators take their concepts from idea to IPO – and beyond. For more information about the Science Center, go to http://www.sciencecenter.org

About the QED Program
The QED Program was launched in April 2009. A common participation agreement that defines matching funds, indirect costs, and intellectual property management, has been signed by 21 universities and research institutions in Pennsylvania, New Jersey, and Delaware: The Children’s Hospital of Philadelphia, Delaware State University, Drexel University, Fox Chase Cancer Center, Harrisburg University of Science and Technology, Lankenau Institute for Medical Research, Lehigh University, Monell Chemical Senses Center, New Jersey Institute of Technology, The Pennsylvania State University, Philadelphia College of Osteopathic Medicine, Philadelphia University, Rowan University, Rutgers University, Temple University, Thomas Jefferson University, University of Delaware, University of Pennsylvania, University of the Sciences in Philadelphia, Widener University, and The Wistar Institute.

Read the full story at http://www.prweb.com/releases/2017/05/prweb14349668.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Trust Transparency Consulting Launches Ingredient Trade Association Incubator Program
2. Cirrascale Cloud Services Announces Deep Learning Classroom Program to Further Assist Higher Education in the Push for AI Integration
3. Industry leaders join Renova Therapeutics to lead preclinical programs into clinical development
4. United Therapeutics Announces $250 Million Share Repurchase Program
5. Volunteers Urge Congressional Support for Funding Science Programs, Higher Education
6. Genisphere Begins Collaborative and Sponsored Research Program with the University of Maryland
7. Astrix Joins BIOVIA Consulting Partner Program
8. Nektar Therapeutics Presents New Preclinical Data for its Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting
9. Doctors Pathology Service (DPS) Joins Growing Biospecimens for Research Program Offered by iSpecimen and the Delaware Health Information Network (DHIN)
10. OncoSec Announces First Technology Access Program Agreement with Inhibrx
11. Soligenix to Present Results from its Ricin Toxin Vaccine Program at the Society of Toxicology 56th Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... 2017 , ... Vortex Biosciences , provider of circulating tumor cell (CTC) ... cells using Vortex microfluidic technology ” in Nature Precision Oncology on May 8th. ... Carlo and Dr. Matthew Rettig at the University of California, Los Angeles. The publication ...
(Date:5/23/2017)... Switzerland (PRWEB) , ... May 23, 2017 , ... ... forces machine manufacturers to re-engineer their control technology again and again. METTLER TOLEDO ... problem for machine manufacturers. The videos illustrate how integration of the ACT350 into ...
(Date:5/21/2017)... ... May 20, 2017 , ... ... the lengthy trial and error process by finding the right antidepressant faster. ... strengthen the doctor-patient relationship through a personalized approach to treatment. , ...
(Date:5/18/2017)... ... May 16, 2017 , ... Clinical Supplies Management (“CSM”), a Great Point Partners ... to grow. CSM has doubled in size over the past six months with ... strategy. , Roger Gasper joins CSM as Chief Financial Officer. Roger has over ...
Breaking Biology Technology:
(Date:4/5/2017)... YORK , April 5, 2017 Today ... is announcing that the server component of the HYPR ... known for providing the end-to-end security architecture that empowers ... HYPR has already secured over 15 million ... makers including manufacturers of connected home product suites and ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities and ... and behavioral), by technology (fingerprint, AFIS, iris recognition, facial ... and others), by end use industry (government and law ... financial and banking, and others), and by region ( ... , Asia Pacific , and the ...
Breaking Biology News(10 mins):